Quick Takeaways
- Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G/A for Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS).
- Disclosed ownership: 8%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"Frazier Life Sciences Public Fund, L.P. disclosed 8% ownership in Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 5.3% | 14,929,001 | 0 | 14,929,001 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P. | |
| FHMLSP, L.P. | 5.3% | 14,929,001 | 0 | 14,929,001 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P. | |
| FHMLSP, L.L.C. | 5.3% | 14,929,001 | 0 | 14,929,001 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C. | |
| Frazier Life Sciences Public Overage Fund, L.P. | 0.8% | 2,373,243 | 0 | 2,373,243 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P., GP of Frazier Life Sciences Public Overage Fund, L.P. | |
| FHMLSP Overage, L.P. | 0.8% | 2,373,243 | 0 | 2,373,243 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P. | |
| FHMLSP Overage, L.L.C. | 0.8% | 2,373,243 | 0 | 2,373,243 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C. | |
| Frazier Life Sciences X, L.P. | 0.6% | 1,670,580 | 0 | 1,670,580 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P. | |
| FHMLS X, L.P. | 0.6% | 1,670,580 | 0 | 1,670,580 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P. | |
| FHMLS X, L.L.C. | 0.6% | 1,670,580 | 0 | 1,670,580 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C. | |
| Frazier Life Sciences XI, L.P. | 1.3% | 3,603,027 | 0 | 3,603,027 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P. | |
| FHMLS XI, L.P. | 1.3% | 3,603,027 | 0 | 3,603,027 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P. | |
| FHMLS XI, L.L.C. | 1.3% | 3,603,027 | 0 | 3,603,027 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C. | |
| James N. Topper | 8% | 22,575,851 | 0 | 22,575,851 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 | |
| Patrick J. Heron | 8% | 22,575,851 | 0 | 22,575,851 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 | |
| Albert Cha | 6.1% | 17,302,244 | 0 | 17,302,244 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021 | |
| James Brush | 6.1% | 17,302,244 | 0 | 17,302,244 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021 | |
| Daniel Estes | 1.3% | 3,603,027 | 0 | 3,603,027 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022 |